Literature DB >> 12704120

Inhibition of response to alpha interferon by Mycobacterium tuberculosis.

Savita Prabhakar1, Yaming Qiao, Yoshihiko Hoshino, Michael Weiden, Antony Canova, Elena Giacomini, Eliana Coccia, Richard Pine.   

Abstract

We previously reported that infection by Mycobacterium tuberculosis, the causative agent of tuberculosis, leads to secretion of alpha/beta interferon (IFN-alpha/beta). While IFN-alpha/beta ordinarily stimulates formation of signal transducer and stimulator of transcription-1 (STAT-1) homodimers and IFN-stimulated gene factor-3 (ISGF-3), only ISGF-3 is found in infected human monocytes and macrophages. We have now investigated the basis for this unusual profile of transcription factor activation and its consequences for regulation of transcription, as well as the impact of infection on response to IFN-alpha. After infection, IFN-alpha stimulation of STAT-1 homodimers is inhibited in monocytes and macrophages, while stimulation of ISGF-3 increases in monocytes but tends to decline in macrophages. Effects of infection on the abundance of ISGF-3 subunits, STAT-1, STAT-2, and interferon regulatory factor 9, and on tyrosine phosphorylation of STAT-1 and STAT-2 explain the observed changes in DNA-binding activity, which correlate with increased or inhibited transcription of genes regulated by ISGF-3 and STAT-1. Infection by Mycobacterium bovis BCG does not inhibit IFN-alpha-stimulated tyrosine phosphorylation of STAT-1, formation of homodimers, or transcription of genes regulated by STAT-1 homodimers, suggesting that inhibition of the response to IFN-alpha/beta by M. tuberculosis is an aspect of pathogenicity. Thus, this well-known feature of infection by pathogenic viruses may also be a strategy employed by pathogenic bacteria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704120      PMCID: PMC153238          DOI: 10.1128/IAI.71.5.2487-2497.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

1.  Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization.

Authors:  Somia Perdow Hickman; John Chan; Padmini Salgame
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

2.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff.

Authors:  Matthew Paulson; Carolyn Press; Eric Smith; Naoko Tanese; David E Levy
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

Review 4.  The host immune response to tuberculosis.

Authors:  N W Schluger; W N Rom
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

5.  Transcriptional stimulation by CaPO4-DNA precipitates.

Authors:  R Pine; D E Levy; N Reich; J E Darnell
Journal:  Nucleic Acids Res       Date:  1988-02-25       Impact factor: 16.971

6.  Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response.

Authors:  E Giacomini; E Iona; L Ferroni; M Miettinen; L Fattorini; G Orefici; I Julkunen; E M Coccia
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

7.  Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation.

Authors:  S Dupuis; C Dargemont; C Fieschi; N Thomassin; S Rosenzweig; J Harris; S M Holland; R D Schreiber; J L Casanova
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

8.  Interferon-alpha induces transient suppressors of cytokine signalling expression in human T cells.

Authors:  C Brender; M Nielsen; C Röpke; M H Nissen; A Svejgaard; N Billestrup; C Geisler; N Ødum
Journal:  Exp Clin Immunogenet       Date:  2001

9.  Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis.

Authors:  Maria Elena Remoli; Elena Giacomini; Georges Lutfalla; Elisabetta Dondi; Graziella Orefici; Angela Battistini; Gilles Uzé; Sandra Pellegrini; Eliana M Coccia
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

10.  Transcriptional induction by interferon. New protein(s) determine the extent and length of the induction.

Authors:  A C Larner; A Chaudhuri; J E Darnell
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

View more
  19 in total

1.  Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.

Authors:  John Kuchtey; Scott A Fulton; Scott M Reba; Clifford V Harding; W Henry Boom
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response.

Authors:  M Lichtner; R Rossi; F Mengoni; S Vignoli; B Colacchia; A P Massetti; I Kamga; A Hosmalin; V Vullo; C M Mastroianni
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

3.  Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9.

Authors:  Daimon P Simmons; David H Canaday; Yi Liu; Qing Li; Alex Huang; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2010-07-21       Impact factor: 5.422

4.  Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis.

Authors:  Jeffrey A Gold; Yoshihiko Hoshino; Satomi Hoshino; Marcus B Jones; Anna Nolan; Michael D Weiden
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

5.  Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells.

Authors:  Sabrina Mariotti; Raffaela Teloni; Elisabetta Iona; Lanfranco Fattorini; Giulia Romagnoli; Maria Cristina Gagliardi; Graziella Orefici; Roberto Nisini
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Evidence for postinitiation regulation of mRNA biogenesis in tuberculosis.

Authors:  Hugh Salamon; Yaming Qiao; Jeff C Cheng; Ken D Yamaguchi; Patricia Soteropoulos; Michael Weiden; Maria Laura Gennaro; Richard Pine
Journal:  J Immunol       Date:  2013-02-01       Impact factor: 5.422

7.  Cutting edge: Vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection.

Authors:  Hugh Salamon; Natalie Bruiners; Karim Lakehal; Lanbo Shi; Janani Ravi; Ken D Yamaguchi; Richard Pine; Maria Laura Gennaro
Journal:  J Immunol       Date:  2014-06-04       Impact factor: 5.422

8.  Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis.

Authors:  Ludovic Desvignes; Andrea J Wolf; Joel D Ernst
Journal:  J Immunol       Date:  2012-05-07       Impact factor: 5.422

9.  Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity.

Authors:  Victor I Ayala; John R Teijaro; Donna L Farber; Susan G Dorsey; Nicholas H Carbonetti
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

10.  Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.

Authors:  Novel N Chegou; Anne K Detjen; Lani Thiart; Elisabetta Walters; Anna M Mandalakas; Anneke C Hesseling; Gerhard Walzl
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.